Minimum import price set for anti-bacterial drug API

AstraZeneca plans overhaul of US listing to attract more investors

UK's pharmaceutical crisis explained as NHS drug prices feared

Novo Nordisk's new boss wins cautious backing after sweeping cuts

Senior UK official asks whether pause in pharma sector spending is 'co-ordinated'

Amid industry headwinds, Biogen breaks ground on new headquarters - The Boston Globe

Nadda holds meet with representatives of pharma, bulk drug, and other sectors